In particular, the report identifies molecules that offer minimally invasive techniques. The increasing availability of advanced genomic and proteomic tools is accelerating research in the cancer biomarker field, leading to the rapid growth of new findings. Biomarkers are discussed and presented by their potential utility in key breast cancer areas, including diagnosis, metastasis, response to therapy, prognosis and disease predisposition. In addition, through a six-monthly is provided (at no additional cost) with this report, helping readers to remain current with new advances and opportunities. As part of this report, biomarkers are classified by their potential utility.